Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Bioorganic Chemistry|May 28, 2026
New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activityBshra A Alsfouk, Hazem Elkady, Walid E Elgammal, et al.
Future Medicinal Chemistry|August 29, 2025
Discovery of new thiadiazole-based VEGFR-2 inhibitors: design, synthesis, cytotoxicity, and apoptosis inductionEslam B Elkaeed, Walid E Elgammal, Hazem Elkady, et al.
RSC Advances|December 20, 2023
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studiesWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.
Future Medicinal Chemistry|July 11, 2024
Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular dockingWalid E Elgammal, Safaa S Shaban, Essam M Eliwa, et al.
RSC Advances|May 8, 2025
New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluationWalid E Elgammal, Hazem Elkady, Reda G Yousef, et al.
International Journal of Molecular Sciences|November 14, 2019
Rational Design and Synthesis of Diverse Pyrimidine Molecules Bearing Sulfonamide Moiety as Novel ERK InhibitorsAhmed H Halawa, Areej A Eskandrani, Walid E Elgammal, et al.
Archiv Der Pharmazie|September 29, 2025
New 1,3,4-Thiadiazole-Based Dual B-Raf/VEGFR-2 Inhibitors With Potential Anti-Breast Activity: Design, Synthesis, In Vitro and In Silico EvaluationsWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.
Archiv Der Pharmazie|July 1, 2025
Development of New Thiadiazole Derivatives as VEGFR-2 Inhibitors With Anticancer and Proapoptotic Activities‏Hazem Elkady, Walid E Elgammal, Mohamed M Khalifa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2025
Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activityBshra A Alsfouk, Walid E Elgammal, Hazem Elkady, et al.
Computational Biology and Chemistry|September 27, 2024
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studiesHazem Elkady, Walid E Elgammal, Hazem A Mahdy, et al.
Pageof 4